Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab for Refractory or Relapsing Churg-Strauss Syndrome
NCT00716651Phase 2Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Jul 2008
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA), sponsored by Universitätsklinikum Schleswig-Holstein. Started Jul 2008; status: completed.
02
Drugs
mepolizumab
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on NCT00716651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716651.